Table 4 Factors associated with the risk of loco-regional recurrence for patients with MIBC treated with definite CCRT.
From: The role of PD-L1 in the radiation response and clinical outcome for bladder cancer
Variables | Odd ratios | 95% confidence interval | p |
---|---|---|---|
PD-L1 staining | 0.164 | 0.047–0.377 | 0.005* |
Clinical stage (T2 vs T3–T4) | 3.817 | 1.026–14.209 | 0.046* |
Treatment response (CR or not) | 5.366 | 1.317–21.858 | 0.019* |
Clinical LN involvement | 0.409 | 0.125–1.337 | 0.139 |